Replies to post #92825 on Biotech Values

[DewDiligence]

Update on generic Gemzar:

http://finance.yahoo.com/news/Teva-Provides-Update-on-bw-255826003.html?x=0&.v=1

Teva is evidently not planning to launch until the appellate court rules on the validity of LLY’s 5,464,826 “use” patent, which is scheduled for a hearing on 5/7/10. Inasmuch as this patent has already been declared unenforceable by the lower court, it’s somewhat surprising that Teva is not launching immediately.